DrugCite
Search

ANGIO SEAL

Adverse Events
Reference
Comments

Most Common Angio Seal Reports to the FDA

What are the most common Angio Seal reports to the FDA?

Unknown (for Use When The Device Pr...
237
Implant, Removal Of
115
Device Remains Implanted
35
Implant, Repositioning Of
15
Device, Removal Of (non-implant)
13
Other (for Use When An Appropriate ...
8
Failure To Deploy
5
Device Issue
4
Migration Of Device Or Device Compo...
3
Blockage Within Device Or Device Co...
2
Dislodged
2
Show More Show More
Use Of Device Issue
2
Break
1
Defective Item
1
Device Maintenance Issue
1
Device, Or Device Fragments Remain ...
1
Fracture
1
Improper Or Incorrect Procedure Or ...
1
Leak
1
Material Fragmentation
1
Misplacement
1
Occlusion Within Device
1
Premature Deployment
1
Seal, Incorrect
1

Devices Similar to Angio Seal

Angio Seal Scientific Publications

What Angio Seal safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Angio Seal. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Angio Seal.